A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2002
10/10/2002	CA2441654A1 Cytoskeleton-associated proteins
10/10/2002	CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002	CA2441252A1 Estrogen replacement therapy
10/10/2002	CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	CA2437789A1 Topical composition comprising an antifungal
10/10/2002	CA2435390A1 Compositions, methods and apparatuses for singlet oxygen delivery
10/09/2002	EP1247865A2 Antibody for use in therapy
10/09/2002	EP1247528A1 Pharmaceutical or cosmetic compositions containing extracts from Arachis hypogaea L
10/09/2002	EP1247527A1 Cosmetic and/or pharmaceutical preparations containing extracts of the plant Litchi chinensis Sonn
10/09/2002	EP1247521A1 Use of biguanide and pyrimidine derivatives for the preparation of a topical skin care composition
10/09/2002	EP1246846A2 Soluble interleukin-20 receptor
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246843A1 Novel fgf homolog zfgf12
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002	EP1246821A2 Process for the preparation of paroxetine and synthetic intermeditates thereof
10/09/2002	EP1246810A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
10/09/2002	EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002	EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002	EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002	EP1246648A2 Dendrimer-photosensitizer complexes for medical applications
10/09/2002	EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002	EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002	EP1246628A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/09/2002	EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002	EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002	EP1246604A1 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin
10/09/2002	EP1246603A1 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP1049467B1 Celecoxib compositions
10/09/2002	EP1014937B1 Antimicrobial wipes
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0892634B1 Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne
10/09/2002	EP0804562B1 Connective tissue growth factor-2
10/09/2002	EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002	EP0625206B1 Human epidermal gene promoter
10/09/2002	CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002	CN1373770A Pseudomycin prodrugs
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/09/2002	CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002	CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002	CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002	CN1373654A Skin-balance moisturizing cream
10/09/2002	CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002	CN1372951A Chinese mediicne composition for regenerating hair
10/09/2002	CN1372949A Medicine for treating pyoderma and its preparing process
10/09/2002	CN1372941A Staphylococcus aureus metabolin gel and its preparing process
10/09/2002	CN1372926A Medicinal ointment containing zinc conjugated linoleate and sodium humate
10/09/2002	CN1372922A Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it
10/09/2002	CN1372880A Hair-growing liquid
10/09/2002	CN1372879A Use of bean products for treating exogenous invasion
10/09/2002	CN1092068C Medicine for treatment of tinea
10/09/2002	CN1092067C Medicine for treating multiple skin diseases and its preparing process
10/09/2002	CN1092063C Capsule for treating acne and plane warts
10/09/2002	CN1092060C Ointment for exterior use for treating burns and scalds
10/09/2002	CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/09/2002	CN1092046C Local medicine composition for healing wound
10/09/2002	CN1092039C Cosmetic cream and production method thereof
10/09/2002	CN1092038C Giant silkworm silk nutrition skin-protection product
10/08/2002	US6462078 Antiinflammatory agents; library of plant extracts
10/08/2002	US6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states
10/08/2002	US6462065 Use of 5-HT3 receptor antagonists for treating musculoeskeletal diseases
10/08/2002	US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002	US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002	US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/08/2002	US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002	US6462019 Inhibitors of proteasomal activity and production for stimulating bone growth
10/08/2002	US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002	US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
10/08/2002	US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002	US6461619 Method for treating wounds, burns and dermatological damage by administering selegiline or desmethylselegiline
10/08/2002	US6461601 Polyalkoxy copolymers as lipase inhibitors and their compositions
10/08/2002	US6461590 Stabilized gas-supersaturated suspensions and methods for their delivery
10/04/2002	CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002	WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002	WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002	WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002	WO2002077174A2 Human cytokine receptor
10/03/2002	WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002	WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002	WO2002077008A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
10/03/2002	WO2002076995A2 2-amino-propanol derivatives
10/03/2002	WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002	WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002	WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002	WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002	WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002	WO2002076939A2 Cysteine protease inhibitors
10/03/2002	WO2002076935A1 Novel a-lipoic acid derivative and use thereof
10/03/2002	WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002	WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002	WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002	WO2002076506A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002	WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
10/03/2002	WO2002076486A2 Histidine-rich glycoprotein
10/03/2002	WO2002076470A1 External skin compositions
10/03/2002	WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors

1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 1065